The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer
Open accessAbstract
BACKGROUND: Prostate cancer (PCa) remains the most common malignancy and the second leading cause of cancer death among men in the United States. PCa exhibits the most striking racial disparity, as African American men are at 1.4 times higher risk of being diagnosed, and 2–3 times higher risk of dying of PCa, compared to Caucasian men. The etiology of the disparity has not been clearly elucidated. The objective of this article is to critically review the literature and summarize the most prominent PCa racial disparities accompanied by proposed explanations. METHODS: The present literature on disparities at presentation, diagnosis, treatment, and survival of African American men affected by PCa was systematically reviewed. Original research as well as relevant review articles were included. RESULTS: African American men persistently present with more advanced disease than Caucasian men, are administered different treatment regimens than Caucasian men, and have shorter progression‐free survival following treatment. In addition, African American men report more treatment‐related side‐effects that translates to the diminished quality of life (QOL). CONCLUSIONS: PCa racial disparity exists at stages of presentation, diagnosis, treatment regimens, and subsequent survival, and the QOL. The disparities are complex involving biological, socio‐economic, and socio‐cultural determinants. These mounting results highlight an urgent need for future clinical, scientific, and socio‐cultural research involving transdisciplinary teams to elucidate the causes for PCa racial disparities. Prostate 71: 985–997, 2011. © 2010 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Stanford, J. L., Feng, Z., Hamilton, A. S., Gilliland, F. D., Stephenson, R. A., Eley, J. W., Albertsen, P. C., Harlan, L. C., & Potosky, A. L. (2000) · JAMA · doi:10.1001/jama.283.3.354 · Cited by 956
Obesity and cancer: the role of dysfunctional adipose tissue
van Kruijsdijk, R. C. M., van der Wall, E., & Visseren, F. L. J. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0372 · Cited by 715
Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men
Freedman, M. L., Haiman, C. A., Patterson, N., McDonald, G. J., Tandon, A., Waliszewska, A., Penney, K., Steen, R. G., Ardlie, K., John, E. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605832103 · Cited by 612
Stephenson, A. J., Kattan, M. W., Eastham, J. A., Dotan, Z. A., Bianco, F. J., Lilja, H., & Scardino, P. T. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.0756 · Cited by 529
Racial and Ethnic Differences in Advanced-Stage Prostate Cancer: the Prostate Cancer Outcomes Study
Hoffman, R. M., Gilliland, F. D., Eley, J. W., Harlan, L. C., Stephenson, R. A., Stanford, J. L., Albertson, P. C., Hamilton, A. S., Hunt, W. C., & Potosky, A. L. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.5.388 · Cited by 441
Age-Specific Reference Ranges for Serum Prostate-Specific Antigen in Black Men
Morgan, T. O., Jacobsen, S. J., McCarthy, W. F., Jacobson, D. J., McLeod, D. G., & Moul, J. W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608013350502 · Cited by 412
Cohen, R. A., & Martinez, M. E. (2009) · PsycEXTRA Dataset · doi:10.1037/e565212009-001 · Cited by 412
Powell, I. J., Bock, C. H., Ruterbusch, J. J., & Sakr, W. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.01.015 · Cited by 292
Dietary factors and risks for prostate cancer among blacks and whites in the United States.
Hayes, R. B., Ziegler, R. G., Gridley, G., Swanson, C., Greenberg, R. S., Swanson, G. M., Schoenberg, J. B., Silverman, D. T., Brown, L. M., Pottern, L. M., et al. (1999) · PubMed · Cited by 280
Prostate-Specific Antigen Values at the Time of Prostate Cancer Diagnosis in African-American Men
Moul, J. W. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530160029029 · Cited by 271
Platz, E. A. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.24.2009 · Cited by 255
Zeliadt, S. B., Ramsey, S. D., Penson, D. F., Hall, I. J., Ekwueme, D. U., Stroud, L., & Lee, J. W. (2006) · Cancer · doi:10.1002/cncr.21822 · Cited by 251
Racial disparities in cancer therapy: Did the gap narrow between 1992 and 2002?
Gross, C. P., Smith, B. D., Wolf, E., & Andersen, M. (2008) · Cancer · doi:10.1002/cncr.23228 · Cited by 246
Circulating levels of leptin, adiposity and breast cancer risk
Wu, M.-H., Chou, Y.-C., Chou, W.-Y., Hsu, G.-C., Chu, C.-H., Yu, C.-P., Yu, J.-C., & Sun, C.-A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604913 · Cited by 195
Smith, A. K., Earle, C. C., & McCarthy, E. P. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.02081.x · Cited by 192
Eton, D. T., Lepore, S. J., & Helgeson, V. S. (2001) · Cancer · doi:10.1002/1097-0142(20010915)92:6<1451::aid-cncr1469>3.0.co;2-r · Cited by 173
Thompson, I. M., Tangen, C. M., Tolcher, A., Crawford, E. D., Eisenberger, M., & Moinpour, C. M. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.3.219 · Cited by 165
Patient Decision Aids for Prostate Cancer Treatment: A Systematic Review of the Literature
Lin, G. A., Aaronson, D. S., Knight, S. J., Carroll, P. R., & Dudley, R. A. (2009) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20039 · Cited by 145
Gaston, K. E., Kim, D., Singh, S. S., Ford, O. H., & Mohler, J. L. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000079761.56154.e5 · Cited by 139
Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer
Shavers, V. L., Brown, M. L., Potosky, A. L., Klabunde, C. N., Davis, W. W., Moul, J. W., & Fahey, A. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.30209.x · Cited by 129
Recent Trends in Black-White Disparities in Cancer Mortality
DeLancey, J. O., Thun, M. J., Jemal, A., & Ward, E. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0131 · Cited by 122
VITAMIN D IN HEALTH AND DISEASE: Vitamin D and the Epidemiology of Prostate Cancer
Schwartz, G. G. (2005) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2005.18403.x · Cited by 116
The Molecular Pathogenesis of Head and Neck Cancer
Klein, J. D., & Grandis, J. R. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.1.10905 · Cited by 115
Moses, K. A., Paciorek, A. T., Penson, D. F., Carroll, P. R., & Master, V. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.2469 · Cited by 110
Serum Lycopene, Other Serum Carotenoids, and Risk of Prostate Cancer in US Blacks and Whites
Vogt, T. M., Mayne, S. T., Graubard, B. I., Swanson, C. A., Sowell, A. L., Schoenberg, J. B., Swanson, G. M., Greenberg, R. S., Hoover, R. N., Hayes, R. B., et al. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.11.1023 · Cited by 106
Marriage and ethnicity predict treatment in localized prostate carcinoma
Denberg, T. D., Beaty, B. L., Kim, F. J., & Steiner, J. F. (2005) · Cancer · doi:10.1002/cncr.20982 · Cited by 102
Racial differences in initial treatment for clinically localized prostate cancer
Hoffman, R. M., Harlan, L. C., Klabunde, C. N., et al. (2003) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2003.21105.x · Cited by 99
Explaining the Race Difference in Prostate Cancer Stage at Diagnosis
Jones, B. A., Liu, W., de Araújo, A. B., Kasl, S. V., Silvera, S. A. N., Soler‐Vilá, H., Curnen, M. G. M., & Dubrow, R. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0203 · Cited by 96
Spirituality and quality of life in low‐income men with metastatic prostate cancer
Zavala, M. W., Maliski, S. L., Kwan, L. C., Fink, A., & Litwin, M. S. (2008) · Psycho-Oncology · doi:10.1002/pon.1460 · Cited by 89
Serum Insulin-Like Growth Factor-I Levels and Prostate Cancer Risk--Interpreting the Evidence
Cohen, P. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.876 · Cited by 81
Stage at Diagnosis and Survival in a Multiethnic Cohort of Prostate Cancer Patients
Oakley-Girvan, I. A., Kolonel, L. N., Gallagher, R. P., Wu, A. H., Felberg, A., & Whittemore, A. S. (2003) · American Journal of Public Health · doi:10.2105/ajph.93.10.1753 · Cited by 73
Spirituality Among African American Cancer Survivors
Hamilton, J. B., Powe, B. D., Pollard, A. B., Lee, K. J., & Felton, A. (2007) · Cancer Nursing · doi:10.1097/01.ncc.0000281730.17985.f5 · Cited by 72
Lower Use of Hospice by Cancer Patients who Live in Minority Versus White Areas
Haas, J. S., Earle, C. C., Orav, E. J., Brawarsky, P., Neville, B. A., Acevedo‐García, D., & Williams, D. R. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-006-0034-y · Cited by 70
Race/Ethnicity and the Intensity of Medical Monitoring Under ‘Watchful Waiting’ for Prostate Cancer
Shavers, V. L., Brown, M. L., Klabunde, C. N., Potosky, A. L., Davis, W. W., Moul, J. W., & Fahey, A. (2004) · Medical Care · doi:10.1097/01.mlr.0000117361.61444.71 · Cited by 69
Jenkins, R., Schover, L. R., Fouladi, R. T., Warneke, C. L., Neese, L. E., Klein, E. A., Zippe, C. D., & Kupelian, P. (2004) · Journal of Sex & Marital Therapy · doi:10.1080/00926230490258884 · Cited by 69
Ethnicity and determinants of quality of life after prostate cancer treatment
Penedo, F. J., Dahn, J. R., Shen, B., Schneiderman, N., & Antoni, M. H. (2006) · Urology · doi:10.1016/j.urology.2005.11.019 · Cited by 68
Earlier age at diagnosis: Another dimension in cancer disparity?
Karami, S., Young, H. A., & Henson, D. E. (2007) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2006.11.004 · Cited by 67
Assessing Linkage Eligibility Bias in the National Health Interview Survey
Aram, J., Zhang, C., Golden, C., Zelaya, C. E., Cox, C. S., Ye, Y., & Mirel, L. B. (2021) · doi:10.15620/cdc:100468 · Cited by 67
Prevalence and correlates of vitamin D status in African American men
Tseng, M., Giri, V. N., Bruner, D. W., & Giovannucci, E. L. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-191 · Cited by 66
Radical prostatectomy: lower rates among African-American men.
Imperato, P. J., Nenner, R. P., & Will, T. O. (1996) · PubMed Central · Cited by 65
Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults
Berrigan, D. A., Potischman, N. A., Dodd, K. W., Hursting, S. D., Lavigne, J. A., Barrett, J. C., & Ballard-Barbash, R. R. (2008) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2008.08.005 · Cited by 60
Spangler, E., Zeigler-Johnson, C. M., Coomes, M., et al. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.07.021 · Cited by 58
Is Ethnicity an Independent Predictor of Prostate Cancer Recurrence After Radical Prostatectomy?
Grossfeld, G. D., Latini, D. M., Downs, T. M., Lubeck, D. P., Mehta, S. S., & Carroll, P. R. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)64179-1 · Cited by 58
Weiss, J. M., Huang, W., Rinaldi, S., Fears, T. R., Chatterjee, N., Chia, D., Crawford, E. D., Kaaks, R., & Hayes, R. B. (2007) · International Journal of Cancer · doi:10.1002/ijc.22921 · Cited by 56
Lange, E. M., Sarma, A. V., Ray, A. M., Wang, Y., Ho, L. A., Anderson, S. A., Cunningham, J. M., & Cooney, K. A. (2008) · Journal of Human Genetics · doi:10.1007/s10038-007-0240-4 · Cited by 55
Cascio, S., Ferla, R., D'Andrea, A., Gerbino, A., Bazan, V., Surmacz, E., & Russo, A. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21843 · Cited by 53
Tewari, A. K., Gold, H. T., Demers, R. Y., Johnson, C. C., Yadav, R., Wagner, E. H., Field, T. S., Divine, G., & Menon, M. (2009) · Urology · doi:10.1016/j.urology.2008.09.081 · Cited by 48
Complications of androgen deprivation therapy in prostate cancer
Schwandt, A., & Garcia, J. A. (2009) · Current Opinion in Urology · doi:10.1097/mou.0b013e32832a082c · Cited by 47
Racial Disparities in Urologic Health Care
Klein, J. B., Nguyen, C. T., Saffore, L., Modlin, C. S., & Modlin, C. S. (2010) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30498-3 · Cited by 44
Ross, L. E., Taylor, Y. J., Richardson, L. C., & Howard, D. L. (2009) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)30878-6 · Cited by 40
Prostate cancer in African-American men and polymorphism in the calcium-sensing receptor
Schwartz, G. G., John, E. M., Rowland, G. W., et al. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.12.11689 · Cited by 33
Racial Differences in Quality of Life Following Prostate Cancer Diagnosis
Halbert, C. H., Coyne, J., Weathers, B., Mahler, B., Delmoor, E., Vaughn, D. J., Malkowicz, S. B., Lee, D. I., & Troxel, A. B. (2010) · Urology · doi:10.1016/j.urology.2009.09.090 · Cited by 32
Purnell, J. Q., Palesh, O. G., Heckler, C. E., Adams, M. J., Chin, N. P., Mohile, S. G., Peppone, L. J., Atkins, J. N., Moore, D. F., Spiegel, D., et al. (2010) · Supportive Care in Cancer · doi:10.1007/s00520-010-0880-3 · Cited by 31
Racial Differences in the Impact of Comorbidities on Survival Among Elderly Men With Prostate Cancer
Putt, M., Long, J. A., Montagnet, C., Silber, J. H., Chang, V. W., Liao, K., Schwartz, J. S., Pollack, C. E., Wong, Y., & Armstrong, K. (2009) · Medical Care Research and Review · doi:10.1177/1077558709333996 · Cited by 31
Abraham, N., Wan, F., Montagnet, C., et al. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.03.035 · Cited by 29
Bañez, L. L., Terris, M. K., Aronson, W. J., Presti, J. C., Kane, C. J., Amling, C. L., & Freedland, S. J. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0502 · Cited by 29
Association of CD14 variant with prostate cancer in African American men
Mason, T. E., Ricks‐Santi, L. J., Chen, W., Apprey, V., Joykutty, J., Ahaghotu, C. A., Kittles, R. A., Bonney, G. E., & Dunston, G. M. (2009) · The Prostate · doi:10.1002/pros.21060 · Cited by 28
McCarty, M. F. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1315 · Cited by 28
Health Disparities in Staging of SEER-Medicare Prostate Cancer Patients in the United States
Mullins, C. D., Onukwugha, E., Bikov, K. A., et al. (2010) · Urology · doi:10.1016/j.urology.2009.10.061 · Cited by 27
Association between ethnicity and prostate cancer outcomes across hospital and surgeon volume groups
Jayadevappa, R., Chhatre, S., Johnson, J. C., & Malkowicz, S. B. (2010) · Health Policy · doi:10.1016/j.healthpol.2010.07.014 · Cited by 26
Perceived Stress and Quality of Life among Prostate Cancer Survivors
Joseph, H. J., Thibault, G. P., & Ruttle-King, J. (2006) · Military Medicine · doi:10.7205/milmed.171.5.425 · Cited by 20
Prostate cancer treatment for economically disadvantaged men
Parsons, J. K., Kwan, L. C., Connor, S. E., Miller, D. C., & Litwin, M. S. (2010) · Cancer · doi:10.1002/cncr.24856 · Cited by 19
Radical prostatectomy and quality of life among African Americans.
Ukoli, F. A. M., Lynch, B., & Adams-Campbell, L. L. (2006) · PubMed · Cited by 10
Prostate cancer among African American men: A review of empirical literature
Dimah, K. P., & Dimah, A. (2003) · Journal of African American Studies · doi:10.1007/s12111-003-1001-x · Cited by 10
Cited by
Cancer health disparities in racial/ethnic minorities in the United States
Zavala, V. A., Bracci, P. M., Carethers, J. M., Carvajal-Carmona, L., Coggins, N. B., Cruz-Correa, M. R., Davis, M., de Smith, A. J., Dutil, J., Figueiredo, J. C., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01038-6 · Cited by 912
DeSantis, C. E., Siegel, R. L., Sauer, A. G., Miller, K. D., Fedewa, S. A., Alcaraz, K. I., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21340 · Cited by 790
Cancer incidence in Nigeria: A report from population-based cancer registries
Jedy-Agba, E., Curado, M. P., Ogunbiyi, O., Oga, E., Fabowale, T., Igbinoba, F., Osubor, G., Otu, T., Kumai, H., Koechlin, A., et al. (2012) · Cancer Epidemiology · doi:10.1016/j.canep.2012.04.007 · Cited by 403
Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer
Gandaglia, G., Karakiewicz, P. I., Briganti, A., Passoni, N. M., Schiffmann, J., Trudeau, V., Graefen, M., Montorsi, F., & Sun, M. (2015) · European Urology · doi:10.1016/j.eururo.2014.07.020 · Cited by 334
Chakravarty, D., Johnson, A., Sklar, J., Lindeman, N. I., Moore, K., Ganesan, S., Lovly, C. M., Perlmutter, J., Gray, S. W., Hwang, J., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02767 · Cited by 266
Metadata
- Authors
- Chornokur, G., Dalton, K., Borysova, M. E., & Kumar, N. B.
- Venue
- The Prostate
- Publisher
- Wiley
- Published
- 2010-12-28
- Volume
- 71
- Issue
- 9
- Pages
- 985-997
- ISSN
- 0270-4137 (ISSN-L)
- 1097-0045
- OpenAlex
- W2070301254
- Cited by
- 343
- References
- 65
- FWCI
- 9.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.